HMG-CoA Reductase Inhibitor class drugs

19 results

  • atorvastatin calcium

    (Atorvastatin calcium)
    NIVAGEN PHARMACEUTICALS, INC.
    Atorvastatin calcium is indicated to reduce the risk of myocardial infarction, stroke, and angina in at-risk adults. It also lowers LDL cholesterol in adults with hyperlipidemia, heterozygous or homozygous familial hypercholesterolemia, and treats primary dysbetalipoproteinemia and hypertriglyceridemia as an adjunct to diet.

  • caduet

    (amlodipine besylate and atorvastatin calcium)
    Pfizer Laboratories Div Pfizer Inc
    CADUET (amlodipine and atorvastatin) is indicated for patients requiring both hypertension management and lipid control. Amlodipine treats high blood pressure and various types of angina, while atorvastatin reduces risk of cardiovascular events and lowers LDL cholesterol in hyperlipidemia.

  • crestor

    (Rosuvastatin)
    AstraZeneca Pharmaceuticals LP
    CRESTOR is indicated for reducing the risk of major cardiovascular events in adults at increased risk, as an adjunct to diet for lowering LDL cholesterol in various hyperlipidemias, and for treating primary dysbetalipoproteinemia and hypertriglyceridemia in adults. It is also used in pediatric patients with familial hypercholesterolemia.

  • ezetimibe and simvastatin

    (Ezetimibe and Simvastatin)
    AvKARE
    Ezetimibe and simvastatin tablets are indicated as adjunct therapy to diet for reducing cholesterol and triglyceride levels in patients with primary or mixed hyperlipidemia, including homozygous familial hypercholesterolemia. They are part of a comprehensive approach to reduce the risk of atherosclerotic vascular disease.

  • fluvastatin sodium

    (Fluvastatin Sodium)
    Lannett Company, Inc.
    Fluvastatin sodium extended-release tablets are indicated for reducing the risk of coronary revascularization and slowing coronary atherosclerosis in adults with coronary heart disease. They also help lower LDL cholesterol in adults with primary hyperlipidemia and in pediatric patients aged 10 and older with heterozygous familial hypercholesterolemia.

  • lipitor

    (atorvastatin calcium)
    Viatris Specialty LLC
    LIPITOR is indicated to reduce the risk of myocardial infarction, stroke, and angina in adults with or without coronary heart disease risk factors. It also lowers LDL cholesterol in adults and children with primary hyperlipidemia, familial hypercholesterolemia, and other dyslipidemias as an adjunct to diet.

  • lovastatin

    (lovastatin)
    Lupin Pharmaceuticals, Inc.
    Lovastatin is indicated for lowering total and LDL cholesterol levels as part of a treatment strategy in individuals with dyslipidemia at risk for atherosclerotic vascular disease, including those with coronary heart disease and hypercholesterolemia. It is also used for primary prevention of coronary heart disease in certain populations.

  • rosuvastatin calcium

    (Rosuvastatin Calcium)
    Shandong New Time Pharmaceutical Co., Ltd.
    Rosuvastatin is indicated for reducing cardiovascular risk in adults without coronary heart disease, lowering LDL-C in various hyperlipidemia types, treating familial hypercholesterolemia in children and adults, and addressing primary dysbetalipoproteinemia and hypertriglyceridemia as an adjunct to diet and other therapies.

  • rosuvastatin calcium

    (Rosuvastatin Calcium)
    UMEDICA LABORATORIES PRIVATE LIMITED
    Rosuvastatin is indicated to reduce cardiovascular event risk in adults without coronary heart disease, lower LDL cholesterol in various forms of hyperlipidemia (primary, familial), and treat dysbetalipoproteinemia and hypertriglyceridemia as an adjunct to diet in both adults and pediatric patients aged 7 years and older.

  • rosuvastatin calcium

    (Rosuvastatin Calcium)
    TORRENT PHARMACEUTICALS LIMITED
    Rosuvastatin is indicated to reduce the risk of major cardiovascular events in adults at increased risk, and as an adjunct to diet for lowering LDL cholesterol in various conditions, including primary hyperlipidemia, heterozygous familial hypercholesterolemia, and homozygous familial hypercholesterolemia in both adults and children.